Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL225111 | 0.91 | APLNR (0.35) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL225096 | 0.88 | APLNR (0.46) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL29726996 | 0.83 | APLNR (0.39) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL16344207 | 0.78 | APLNR (0.30) | APLNR | |
| SCHEMBL3778963 | 0.75 | APLNR (0.48) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL5883941 | 0.71 | APLNR (0.67) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL28297608 | 0.71 | APLNR (0.37) | APLNRCYP2C19ALDH1A1LMNACYP3A4 | |
| SCHEMBL383633 | 0.70 | TSHR (0.36) | ALDH1A1TDP1HTT | |
| SCHEMBL317158 | 0.70 | TSHR (0.36) | ALDH1A1TDP1HTT | |
| SCHEMBL3129361 | 0.70 | APLNR (0.46) | APLNRCYP2C19ALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12622985-B2 | Sterilization method for medical rubber part | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20240189463-A1 | STERILIZATION METHOD FOR MEDICAL RUBBER PART | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622985-B2 | Sterilization method for medical rubber part | TMEM97, SEC61A1, SQLE | APLNR 4453/4885CYP2C19 8/4885ALDH1A1 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.